American Thyroid Association. Scientists & Physicians Dedicated to Better Understanding & Treatment of Thyroid Diseases.

Hyperthyroidism

Print page Email page

High serum thyrotropin-receptor antibody levels predict recurrent hyperthyroidism in patients with Graves’ disease

Thyroid Digest July 2004The background of the study. Hyperthyroidism caused by Graves’ disease is due to thyroid stimulation by thyrotropin (TSH)-receptor-stimulating antibodies (TSHR-Abs). In this study the predictive value of measurements of serum TSHR-Abs using a new assay was tested.

How the study was done. The study subjects were 73 women and 20 men with hyperthyroidism due to Graves’ disease who had been treated with methimazole or carbimazole for five months. At that time, serum TSHR-Abs and serum TSH were measured. The patients were then followed for a median duration of 22 months.

The results of the study. Sixty patients (65 percent) had recurrent hyperthyroidism within 24 months after stopping antithyroid drug therapy, and 33 patients (35 percent) remained euthyroid during a median follow-up period of 17 months.

All patients had high serum TSHR-Ab values at the end of treatment. The median value was 8.6 U/L (range, 1.1 to 150) in the patients who had recurrent hyperthyroidism, and it was 2.1 U/L (range, 1.1 to 22.3) in the patients who remained euthyroid. Twenty-eight of the 29 patients with a value >10 U/L had recurrent hyperthyroidism. At the same time, the median serum TSH value was 0.008 mU/L in the patients who had recurrent hyperthyroidism and 0.20 mU/L in the patients who remained euthyroid.

The conclusions of the study. High serum TSHR-Ab values after antithyroid drug therapy predict recurrent hyperthyroidism in patients with Graves’ disease after cessation of therapy.

The original article. Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, Seissler J. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves’ disease. Horm Metab Res 2004;36:92-6.


 

Next Article: Antithyroid drug therapy may be associated with antineutrophil cytoplasmic antibodies in patients with hyperthyroidism due to Graves’ disease

 

Thyroid Digest Index | July 2004 Thyroid Digest
Privacy Policy | Terms & Conditions | Contact Us
Site Design by Intertwine Systems, Inc.